Keyphrases
Epitope
90%
Gp120
61%
Binding Site
52%
Monoclonal Antibody
40%
Human Immunodeficiency Virus Type 1 (HIV-1)
34%
Protein Blotting
31%
Nicotinic Acetylcholine Receptor (nAChR)
31%
Acetylcholine Receptor (AChR)
30%
Phage
28%
α-bungarotoxin
28%
Recombinant
24%
Random Peptide Library
24%
CD4-induced
20%
Virus
18%
Viral Glycoprotein
18%
Toxin Binding
18%
Glycoprotein
17%
Torpedo
16%
Acetylcholine
15%
Epitope Mapping
13%
Filamentous Bacteriophage
13%
Escherichia Coli
13%
Phage Display
13%
Polyclonal Sera
12%
Membrane Filter
12%
Humoral Immune Response
12%
Receptor-binding Domain
12%
Streptococcus Pneumoniae
12%
Decoy
12%
Phage Display Library
12%
Bungarotoxin Binding Site
11%
D-tubocurarine
11%
Random Peptides
10%
125I
10%
Amino Acids
10%
Torpedo Californica
10%
B-cell Epitope
10%
Envelope Protein
10%
Positively Charged
9%
B Cells
9%
Computational Prediction
9%
(I)-envelope
9%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
9%
Adhesin
9%
Hydrazide
8%
Neutralizing Antibodies
8%
Neutralizing Epitope
8%
Acetylcholine Receptor Subunit
8%
Infectious Diseases
8%
Recombinant Protein
8%
Immunology and Microbiology
Epitope
100%
Peptides
66%
CD4
57%
Human Immunodeficiency Virus 1
51%
Monoclonal Antibody
38%
Bacteriophage
36%
Human Immunodeficiency Virus
32%
Binding Site
29%
Phage Display
28%
B Cell
27%
Glycoprotein
24%
Peptide Library
20%
Humoral Immunity
18%
Conformation
15%
Virus
15%
Epitope Mapping
13%
Escherichia coli
13%
Receptor Binding
12%
Streptococcus pneumonia
12%
Pneumococcus
11%
Neutralization
11%
Nicotinic Acetylcholine Receptor
10%
Single-Chain Variable Fragment
10%
Amino Acid
9%
Conformational Transition
9%
Infectious Agent
9%
Neutralizing Antibody
9%
Antibody Specificity
9%
SARS Coronavirus
9%
Lectin
8%
Thymocyte
8%
Peanut Agglutinin
8%
Cell Wall
8%
Immunogenicity
7%
Conformational Epitope
7%
Immune Response
6%
Complex Formation
6%
Carboxy Terminal Sequence
6%
Amino Terminal Sequence
6%
Dynamics
6%
Spike
6%
Protein Binding
6%
Cell Surface
5%
Enterobacteria Phage Fd
5%
Amino Acid Sequence
5%
Envelope Glycoprotein GP120
5%
Cross-Reactivity
5%